Miwa Kurimoto Selected Research

Miwa Kurimoto Research Topics

2	Heavy Chain Disease 01/2016 - 01/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 09/2009 - 10/2008
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2020
1	Enteritis 08/2020
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 06/2018
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2016
1	Heart Failure 12/2015
1	Nausea 12/2015
1	Vomiting 12/2015
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2015
1	T-Cell Lymphoma (Lymphoma, T Cell) 09/2015
1	Aplastic Anemia (Anemia, Hypoplastic) 09/2015
1	Thrombocytopenia (Thrombopenia) 03/2015
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2015
1	Genetic Translocation (Chromosomal Translocation) 09/2009
1	Neoplasms (Cancer) 09/2009
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2008

3	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2016 - 10/2008
1	Azacitidine (5 Azacytidine)FDA Link 08/2020
1	Alkylating AgentsIBA 06/2018
1	Rituximab (Mabthera)FDA Link 06/2018
1	nilotinib FDA Link 12/2015
1	Imatinib Mesylate (Gleevec)FDA Link 12/2015
1	Dasatinib (BMS 354825)FDA Link 12/2015
1	CytokinesIBA 09/2015
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 09/2015
1	Inosine Triphosphate (ITP)IBA 03/2015
1	AutoantibodiesIBA 03/2015
1	Immunoglobulin A (IgA)IBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Cyclin D3IBA 09/2009
1	CD5 AntigensIBA 09/2009

2	Therapeutics 06/2018 - 09/2015